博奥生物品牌怎么样 申请店铺

我要投票 博奥生物在基因检测行业中的票数:12 更新时间:2024-11-22
博奥生物是哪个国家的品牌?「博奥生物」是 博奥生物集团有限公司 旗下著名品牌。该品牌发源于北京市,由创始人程总在2000年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
博奥生物怎么样

成立于2000年,清华控股旗下,生命科学研究和健康产业的企业,打造集健康产品/健康管理和医疗康复于一体的大健康产业版块。

博奥生物集团有限公司于2000年9月30日在国务院、发改委、科技部、教育部、卫生部和北京市领导大力支持下,以清华大学为依托、联合华中科技大学、中国医学科学院、军事医学科学院注册成立,是生命科学研究和健康产业的国有创新型高科技企业。公司总部位于北京,现有员工2000多人,研发、生产、运营和服务基地超过10万平方米。

公司以生物芯片为核心技术平台,拥有研发、生产、销售以及全国第三方独立医学检验所服务为一体的大医学完整产业链,并响应国家关于“预防为主”的健康方针,将现代医学与中国传统医学紧密结合,打造出集健康产品、健康管理和医疗康复于一体的大健康产业版块。迄今,博奥生物在国内已经形成了北京、上海、重庆、成都等大型产业化基地,并形成了以北京博奥晶典生物技术有限公司为核心的产业化平台。

成立18年来,博奥生物依托清华大学和生物芯片北京国家工程研究中心雄厚的研发实力,已成功开发出生物芯片及相关试剂耗材、仪器设备、软件数据库、生命科学服务、临床检验服务、健康管理等系列数十项具有自主知识产权的产品和服务。公司先后获得德国TÜV莱茵公司颁发的ISO9001、ISO13485、ISO14000、ISO18000、ISO27000质量管理体系认证证书、美国组织相容性及遗传学协会(ASHI)认证证书和中国合格评定国家认可委员会实验室认证证书,其产品获得CFDA、CE 、GS、CB等国内外各类认证证书100余项。至今,博奥生物已在全球获得专利授权300余项,专利转化率较高。

因其优良的研发、生产、营销和服务团队,以及生物芯片技术平台和高标准的质保体系,博奥生物除与国内近百家三甲医院、高校、公安和司法机构建立了战略合作,还与罗氏应用科学、罗氏诊断、昂飞、热电等国际生命科学和医学诊断领域的公司建立了伙伴关系,产品及服务出口北美、欧洲、亚洲等三十多个国家和地区。其中,诊断用生物芯片及相关仪器产品已进入英国、德国、瑞典、意大利、西班牙、奥地利、瑞士、葡萄牙、芬兰、丹麦、日本、新加坡等国家的数百家医院。

Founded in 2000, Tsinghua holdings, a life science research and health industry enterprise, has created a large health industry section integrating health products / health management and medical rehabilitation. On September 30, 2000, with the support of the State Council, the national development and Reform Commission, the Ministry of science and technology, the Ministry of education, the Ministry of health and the leaders of Beijing Municipality, Bo'ao biological Group Co., Ltd. was established on the basis of Tsinghua University and registered with Huazhong University of science and technology, the Chinese Academy of Medical Sciences and the Academy of Military Medical Sciences. It is a state-owned innovative high-tech enterprise in life science research and health industry. The company is headquartered in Beijing, with more than 2000 employees and over 100000 square meters of R & D, production, operation and service bases. With biochip as the core technology platform, the company has a complete industrial chain of large-scale medicine integrating R & D, production, sales and the services of the national third-party independent medical laboratory. In response to the national health policy of "prevention first", the company closely combines modern medicine with traditional Chinese medicine to create a large-scale health industry integrating health products, health management and medical rehabilitation Industry forum. So far, Boao biology has formed large-scale industrialization bases in China, such as Beijing, Shanghai, Chongqing, Chengdu, and formed an industrialization platform with Beijing Boao Jingdian Biotechnology Co., Ltd. as the core. Since its establishment 18 years ago, relying on the strong R & D strength of Tsinghua University and biochip Beijing National Engineering Research Center, BOCOG bio has successfully developed dozens of products and services with independent intellectual property rights, including biochip and related reagent consumables, instruments and equipment, software database, life science services, clinical testing services, health management, etc. The company has successively obtained ISO9001, ISO13485, ISO14000, ISO18000, ISO27000 quality management system certification issued by Germany t Ü V Rhine company, Ashi certification and laboratory certification issued by China National Accreditation for conformity assessment. Its products have obtained more than 100 kinds of certification certificates at home and abroad, such as CFDA, CE, GS, CB, etc. So far, Bo'ao biology has obtained more than 300 patent authorizations in the world, with a high patent conversion rate. Due to its excellent R & D, production, marketing and service team, as well as the biochip technology platform and high standard quality assurance system, Boao biology has established strategic cooperation with nearly 100 top three hospitals, universities, public security and judicial institutions in China, as well as partnerships with companies in international life science and medical diagnosis fields such as Roche Applied Science, Roche diagnosis, onfe, thermoelectricity, etc Products and services are exported to more than 30 countries and regions in North America, Europe and Asia. Among them, diagnostic biochip and related instrument products have entered hundreds of hospitals in Britain, Germany, Sweden, Italy, Spain, Austria, Switzerland, Portugal, Finland, Denmark, Japan, Singapore and other countries.

本文链接: https://brand.waitui.com/126365a18.html 联系电话:010-80726868

千城特选小程序码

7×24h 快讯

李彦宏:百度文库AI功能月活用户超5000万,同比增长超300%

36氪获悉,百度2024年第三季度财报电话会上,百度创始人、董事长兼首席执行官李彦宏披露,今年9月,百度文库AI功能月活用户突破5000万,同比增长超300%。此外,用户的付费意愿不断增强,第三季度文库的订阅收入同比增长23%。在近期举办的百度世界2024上,百度文库与百度网盘联合推出了工具类智能体“自由画布”,亮相首日即吸引超20万人排队预约。

15分钟前

李彦宏:Q3智能云营收快速增长,AI收入占比提升至超11%

36氪获悉,在百度2024年第三季度财报电话会上,百度创始人、董事长兼首席执行官李彦宏公布,三季度,百度智能云营收达49亿元,同比增长11 %,Non-GAAP 经营利润率同比提升。其中,AI相关收入占比持续提升至超11%。据IDC报告,在中国AI公有云市场,百度智能云已连续五年位居第一。

15分钟前

热门中概股美股盘前普跌,拼多多跌超10%

36氪获悉,热门中概股美股盘前普跌,截至发稿,拼多多跌超10%,小鹏汽车、爱奇艺跌超4%,百度、B站跌超2%,蔚来跌超1%。

15分钟前

我国载人登月任务已全面进入初样研制阶段

中国载人航天工程总设计师周建平21日在深圳召开的第六届载人航天学术大会上表示,我国载人月球探测工程载人登月任务已经完成了前期的关键技术攻关和深化论证,目前全面进入了初样研制阶段。“目前,长征十号运载火箭、梦舟载人飞船、揽月月面着陆器、载人月球车等初样产品正在紧张研制过程中。不少初样产品已经研制出来,正在进行相关测试。”周建平说。(新华社)

15分钟前

李彦宏:百度将于2025年初发布新版大模型

36氪获悉,在百度2024年第三季度财报电话会上,百度创始人、董事长兼首席执行官李彦宏透露,百度将于2025年初发布文心大模型的新版本,以巩固在基础模型上的领先优势。李彦宏表示,11月,文心大模型日均调用量达15亿,日均处理Tokens文本超1.7万亿。相较一年前首次披露的5000万次日均调用量,增长30倍。

15分钟前

本页详细列出关于恒特基因的品牌信息,含品牌所属公司介绍,恒特基因所处行业的品牌地位及优势。
咨询